Stock Code
688016.SH
Stock Code
688016.SH
Technology Innovation, People Centric
Endovastec™ is committed to provide trustworthy and universal access to state-of-the-art solutions of prolonging
and reshaping all lives, and to build a people centric enterprise ranking as a global leader of evolving and
emerging medical technologies through continuous innovation.
Products
Endovastec™ is committed to R&D, manufacturing, and sales of aortic and peripheral vascular interventional devices,
and our main products are thoracic and abdominal aortic stent grafts, stent grafts in surgical operation,
drug coated PTA balloon catheters, and PTA balloon catheters etc.
Endovastec™ Completes Its First Implantation of Castor™ Branched Stent-Graft and Hercules™-LP Stent Graft in Singapore
Recently, the first implantation of the Castor™ Branched Aortic Stent-Graft and Delivery System (Castor™ Branched Stent-Graft) and Hercules™ Thoracic Stent Graft with Low Profile Delivery System covered stent (Hercules™-LP Stent Graft) developed by Endovastec™, was completed at Tan Tock Seng Hospital by Professor Glenn Tan, Professor Pua Uei, Professor Lawrence Quek, and their team. This marks the first clinical use of Endovastec™’s products in Singapore.
16 Nov 2023
Endovastec™ completes the first clinical implantation of Minos™ Stent Graft System in Azerbaijan
Recently, Endovastec™’s Minos™ Abdominal Aortic Stent-Graft and Delivery System (Minos™) was successfully implanted in the first clinical case at Baku Merkezi Hospital in Azerbaijan. The surgery was performed by Professor Kamuran Musayev and his vascular surgery team.
29 Aug 2023
Endovastec™ Achieves Its First Clinical Implantation of Reewarm™ PTX DCB Catheter in Brazil
Recently, Reewarm™ PTX Drug Coated Balloon (DCB) Catheter, developed by Endovastec™, has been successfully implanted for the first time in Brazil, showing the product’s continued proliferation in international markets to serve patients worldwide. Dr. Flávio Meireles, Dr. Pedro Vilas Boas, and their team at Paulo Sacramento Hospital in Sao Paulo, Brazil, completed this operation.
14 Aug 2023
Endovastec™ participates in the Congresso International de Cirurgia Endovascular
Recently, the 2023 International Congress of Endovascular Surgery (CICE) was held in Brazil, and Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (Endovastec™) was invited to participate, set up an exhibition booth, and welcome domestic and international experts to participate in academic discussions.
26 May 2023
Endovastec™ Presents Flagship Products at CICE 2022
Recently, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”) held a seminar at the International Congress of Endovascular Surgery (Congresso International de Cirurgia Endovascular, CICE 2022) in Brazil, engaging local and global experts.
04 Jul 2022
Endovastec™ Castor™ Debuted at the First eCICE Conference in Brazil
São Paulo, Brazil, 30 October 2020 — The first virtual International Congress of Endovascular Surgery (eCongresso Internacional de Cirurgia Endovascular (eCICE)) kicked off as an online event from 7 – 8th September, 2020. As an influential conference in Latin America in the field of vascular surgery, the congress brought together vascular surgeons from around the world to showcase recent academic insights and developments in several cutting-edge application areas of endovascular treatment. Castor™ Branched Aortic Stent-Graft System (the “Castor™ Stent”), the world’s first stent system of the kind developed by Shanghai MicroPort Endovascular MedTech(Group) Co., Ltd. (“Endovastec™”), was launched on eCICE's live case demonstration.
19 Sept 2020
About us
Products
Investor Relations
Telephone:(86) (21) 38139300
Address:Building #1,3399 Kangxin Rd., SIMZ Century Medicine Park, Shanghai201318,P.R. China
Fax:(86) (21) 33750026
Endovastec™ WeChat
©Copyright 1998-2020, Shanghai MicroPort Endovascular MedTech（Group）Co., Ltd.
Internet Drug Information Service Qualification Certificate No.: (Hu) - Non-operating -2020-0065
Website record/ license No.：沪ICP备14048493号-1 
HGWA Bei No.31011502014536
The registered trademarks of “微创", "MicroPort" and"
" are registered trademarks of Shanghai MicroPort Medical (Group) Co., Ltd., they have been authorized to be used by Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd., and no other party shall use such trademarks without prior written permission thereof.
.png)
